Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

Luis Ortega-Paz, Mattia Galli, Davide Capodanno, Francesco Franchi, Fabiana Rollini, Behnood Bikdeli, Roxana Mehran, Gilles Montalescot, C Michael Gibson, Renato D Lopes, Felicita Andreotti, Dominick J Angiolillo

Open source

DOI: 10.1093/ehjcvp/pvab070
Published: 2021-09-14
Container: European Heart Journal - Cardiovascular Pharmacotherapy
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvab070,
  title = {Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials},
  author = {Luis Ortega-Paz and Mattia Galli and Davide Capodanno and Francesco Franchi and Fabiana Rollini and Behnood Bikdeli and Roxana Mehran and Gilles Montalescot and C Michael Gibson and Renato D Lopes and Felicita Andreotti and Dominick J Angiolillo},
  year = {2021},
  journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
  doi = {10.1093/ehjcvp/pvab070},
  url = {https://doi.org/10.1093/ehjcvp/pvab070}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
AU  - Luis Ortega-Paz
AU  - Mattia Galli
AU  - Davide Capodanno
AU  - Francesco Franchi
AU  - Fabiana Rollini
AU  - Behnood Bikdeli
AU  - Roxana Mehran
AU  - Gilles Montalescot
AU  - C Michael Gibson
AU  - Renato D Lopes
AU  - Felicita Andreotti
AU  - Dominick J Angiolillo
PY  - 2021
JO  - European Heart Journal - Cardiovascular Pharmacotherapy
DO  - 10.1093/ehjcvp/pvab070
UR  - https://doi.org/10.1093/ehjcvp/pvab070
ER  -

APA

Ortega-Paz, L., Galli, M., Capodanno, D., Franchi, F., Rollini, F., Bikdeli, B., Mehran, R., Montalescot, G., Gibson, C. M., Lopes, R. D., Andreotti, F., & Angiolillo, D. J. (2021). Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvab070

Source records

crossref · retrieved 2026-09-27T07:48:50.824Z